新型CT放射组学模型预测可切除胰腺腺癌术后早期复发:中国单中心回顾性研究

IF 2 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Xinze Du, Yongsu Ma, Kexin Wang, Xiejian Zhong, Jianxin Wang, Xiaodong Tian, Xiaoying Wang, Yinmo Yang
{"title":"新型CT放射组学模型预测可切除胰腺腺癌术后早期复发:中国单中心回顾性研究","authors":"Xinze Du,&nbsp;Yongsu Ma,&nbsp;Kexin Wang,&nbsp;Xiejian Zhong,&nbsp;Jianxin Wang,&nbsp;Xiaodong Tian,&nbsp;Xiaoying Wang,&nbsp;Yinmo Yang","doi":"10.1002/acm2.70092","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Purpose</h3>\n \n <p>To assess the predictive capability of CT radiomics features for early recurrence (ER) of pancreatic ductal adenocarcinoma (PDAC).</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Postoperative PDAC patients were retrospectively selected, all of whom had undergone preoperative CT imaging and surgery. Both patients with resectable or borderline-resectable pancreatic cancer met the eligibility criteria in this study. However, owing to the differences in treatment strategies and such, this research mainly focused on patients with resectable pancreatic cancer. All patients were subject to follow-up assessments for a minimum of 9 months. A total of 250 cases meeting the inclusion criteria were included. A clinical model, a conventional radiomics model, and a deep-radiomics model were constructed for ER prediction (defined as occurring within 9 months) in the training set. A model based on the TNM staging was utilized as a baseline for comparison. Assessment of the models' performance was based on the area under the receiver operating characteristic curve (AUC). Additionally, precision-recall (PR) analysis and calibration assessments were conducted for model evaluation. Furthermore, the clinical utility of the models was evaluated through decision curve analysis (DCA), net reclassification improvement (NRI), and improvement of reclassification index (IRI).</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>In the test set, the AUC values for ER prediction were as follows: TNM staging, ROC-AUC = 0.673 (95% CI: 0.550, 0.795), PR-AUC = 0.362 (95% CI: 0.493, 0.710); clinical model, ROC-AUC = 0.640 (95% CI: 0.504, 0.775), PR-AUC = 0.481 (95% CI: 0.520, 0.735); radiomics model, ROC-AUC = 0.722 (95% CI: 0.604, 0.839), PR-AUC = 0.575 (95% CI: 0.466, 0.686); and deep-radiomics model, which exhibited the highest ROC-AUC of 0.895 (95% CI: 0.820, 0.970), PR-AUC = 0.834 (95% CI: 0.767, 0.923). The difference in both ROC-AUC and PR-AUC for the deep-radiomics model was statistically significant when compared to the other scores (all <i>p</i> &lt; 0.05). The DCA curve of the deep-radiomics model outperformed the other models. NRI and IRI analyses demonstrated that the deep-radiomics model significantly enhances risk classification compared to the other prediction methods (all <i>p</i> &lt; 0.05).</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>The predictive performance of deep features based on CT images exhibits favorable outcomes in predicting early recurrence.</p>\n </section>\n </div>","PeriodicalId":14989,"journal":{"name":"Journal of Applied Clinical Medical Physics","volume":"26 6","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/acm2.70092","citationCount":"0","resultStr":"{\"title\":\"Novel CT radiomics models for the postoperative prediction of early recurrence of resectable pancreatic adenocarcinoma: A single-center retrospective study in China\",\"authors\":\"Xinze Du,&nbsp;Yongsu Ma,&nbsp;Kexin Wang,&nbsp;Xiejian Zhong,&nbsp;Jianxin Wang,&nbsp;Xiaodong Tian,&nbsp;Xiaoying Wang,&nbsp;Yinmo Yang\",\"doi\":\"10.1002/acm2.70092\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Purpose</h3>\\n \\n <p>To assess the predictive capability of CT radiomics features for early recurrence (ER) of pancreatic ductal adenocarcinoma (PDAC).</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>Postoperative PDAC patients were retrospectively selected, all of whom had undergone preoperative CT imaging and surgery. Both patients with resectable or borderline-resectable pancreatic cancer met the eligibility criteria in this study. However, owing to the differences in treatment strategies and such, this research mainly focused on patients with resectable pancreatic cancer. All patients were subject to follow-up assessments for a minimum of 9 months. A total of 250 cases meeting the inclusion criteria were included. A clinical model, a conventional radiomics model, and a deep-radiomics model were constructed for ER prediction (defined as occurring within 9 months) in the training set. A model based on the TNM staging was utilized as a baseline for comparison. Assessment of the models' performance was based on the area under the receiver operating characteristic curve (AUC). Additionally, precision-recall (PR) analysis and calibration assessments were conducted for model evaluation. Furthermore, the clinical utility of the models was evaluated through decision curve analysis (DCA), net reclassification improvement (NRI), and improvement of reclassification index (IRI).</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>In the test set, the AUC values for ER prediction were as follows: TNM staging, ROC-AUC = 0.673 (95% CI: 0.550, 0.795), PR-AUC = 0.362 (95% CI: 0.493, 0.710); clinical model, ROC-AUC = 0.640 (95% CI: 0.504, 0.775), PR-AUC = 0.481 (95% CI: 0.520, 0.735); radiomics model, ROC-AUC = 0.722 (95% CI: 0.604, 0.839), PR-AUC = 0.575 (95% CI: 0.466, 0.686); and deep-radiomics model, which exhibited the highest ROC-AUC of 0.895 (95% CI: 0.820, 0.970), PR-AUC = 0.834 (95% CI: 0.767, 0.923). The difference in both ROC-AUC and PR-AUC for the deep-radiomics model was statistically significant when compared to the other scores (all <i>p</i> &lt; 0.05). The DCA curve of the deep-radiomics model outperformed the other models. NRI and IRI analyses demonstrated that the deep-radiomics model significantly enhances risk classification compared to the other prediction methods (all <i>p</i> &lt; 0.05).</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusion</h3>\\n \\n <p>The predictive performance of deep features based on CT images exhibits favorable outcomes in predicting early recurrence.</p>\\n </section>\\n </div>\",\"PeriodicalId\":14989,\"journal\":{\"name\":\"Journal of Applied Clinical Medical Physics\",\"volume\":\"26 6\",\"pages\":\"\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2025-04-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/acm2.70092\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Applied Clinical Medical Physics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/acm2.70092\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Applied Clinical Medical Physics","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/acm2.70092","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

摘要

目的:探讨CT放射组学特征对胰腺导管腺癌(PDAC)早期复发的预测能力。方法:回顾性选择PDAC术后患者,所有患者术前均行CT成像和手术。可切除或边缘性可切除胰腺癌患者均符合本研究的入选标准。然而,由于治疗策略等方面的差异,本研究主要集中在可切除的胰腺癌患者。所有患者均接受至少9个月的随访评估。符合纳入标准的病例共250例。构建临床模型、常规放射组学模型和深度放射组学模型来预测训练集中的ER(定义为9个月内发生的ER)。基于TNM分期的模型被用作比较的基线。模型的性能评估是基于接受者工作特征曲线(AUC)下的面积。此外,还进行了精确召回率(PR)分析和校准评估。此外,通过决策曲线分析(DCA)、净重分类改善(NRI)和重分类指数改善(IRI)来评估模型的临床实用性。结果:在测试集中,预测ER的AUC值如下:TNM分期,ROC-AUC = 0.673 (95% CI: 0.550, 0.795), PR-AUC = 0.362 (95% CI: 0.493, 0.710);临床模型,ROC-AUC = 0.640 (95% CI: 0.504, 0.775), PR-AUC = 0.481 (95% CI: 0.520, 0.735);放射组学模型,ROC-AUC = 0.722 (95% CI: 0.604, 0.839), PR-AUC = 0.575 (95% CI: 0.466, 0.686);deep-radiomics模型的ROC-AUC最高,为0.895 (95% CI: 0.820, 0.970), PR-AUC = 0.834 (95% CI: 0.767, 0.923)。与其他评分相比,深度放射组学模型的ROC-AUC和PR-AUC的差异具有统计学意义(均为p)。结论:基于CT图像的深度特征预测在预测早期复发方面表现良好。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Novel CT radiomics models for the postoperative prediction of early recurrence of resectable pancreatic adenocarcinoma: A single-center retrospective study in China

Novel CT radiomics models for the postoperative prediction of early recurrence of resectable pancreatic adenocarcinoma: A single-center retrospective study in China

Purpose

To assess the predictive capability of CT radiomics features for early recurrence (ER) of pancreatic ductal adenocarcinoma (PDAC).

Methods

Postoperative PDAC patients were retrospectively selected, all of whom had undergone preoperative CT imaging and surgery. Both patients with resectable or borderline-resectable pancreatic cancer met the eligibility criteria in this study. However, owing to the differences in treatment strategies and such, this research mainly focused on patients with resectable pancreatic cancer. All patients were subject to follow-up assessments for a minimum of 9 months. A total of 250 cases meeting the inclusion criteria were included. A clinical model, a conventional radiomics model, and a deep-radiomics model were constructed for ER prediction (defined as occurring within 9 months) in the training set. A model based on the TNM staging was utilized as a baseline for comparison. Assessment of the models' performance was based on the area under the receiver operating characteristic curve (AUC). Additionally, precision-recall (PR) analysis and calibration assessments were conducted for model evaluation. Furthermore, the clinical utility of the models was evaluated through decision curve analysis (DCA), net reclassification improvement (NRI), and improvement of reclassification index (IRI).

Results

In the test set, the AUC values for ER prediction were as follows: TNM staging, ROC-AUC = 0.673 (95% CI: 0.550, 0.795), PR-AUC = 0.362 (95% CI: 0.493, 0.710); clinical model, ROC-AUC = 0.640 (95% CI: 0.504, 0.775), PR-AUC = 0.481 (95% CI: 0.520, 0.735); radiomics model, ROC-AUC = 0.722 (95% CI: 0.604, 0.839), PR-AUC = 0.575 (95% CI: 0.466, 0.686); and deep-radiomics model, which exhibited the highest ROC-AUC of 0.895 (95% CI: 0.820, 0.970), PR-AUC = 0.834 (95% CI: 0.767, 0.923). The difference in both ROC-AUC and PR-AUC for the deep-radiomics model was statistically significant when compared to the other scores (all p < 0.05). The DCA curve of the deep-radiomics model outperformed the other models. NRI and IRI analyses demonstrated that the deep-radiomics model significantly enhances risk classification compared to the other prediction methods (all p < 0.05).

Conclusion

The predictive performance of deep features based on CT images exhibits favorable outcomes in predicting early recurrence.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.60
自引率
19.00%
发文量
331
审稿时长
3 months
期刊介绍: Journal of Applied Clinical Medical Physics is an international Open Access publication dedicated to clinical medical physics. JACMP welcomes original contributions dealing with all aspects of medical physics from scientists working in the clinical medical physics around the world. JACMP accepts only online submission. JACMP will publish: -Original Contributions: Peer-reviewed, investigations that represent new and significant contributions to the field. Recommended word count: up to 7500. -Review Articles: Reviews of major areas or sub-areas in the field of clinical medical physics. These articles may be of any length and are peer reviewed. -Technical Notes: These should be no longer than 3000 words, including key references. -Letters to the Editor: Comments on papers published in JACMP or on any other matters of interest to clinical medical physics. These should not be more than 1250 (including the literature) and their publication is only based on the decision of the editor, who occasionally asks experts on the merit of the contents. -Book Reviews: The editorial office solicits Book Reviews. -Announcements of Forthcoming Meetings: The Editor may provide notice of forthcoming meetings, course offerings, and other events relevant to clinical medical physics. -Parallel Opposed Editorial: We welcome topics relevant to clinical practice and medical physics profession. The contents can be controversial debate or opposed aspects of an issue. One author argues for the position and the other against. Each side of the debate contains an opening statement up to 800 words, followed by a rebuttal up to 500 words. Readers interested in participating in this series should contact the moderator with a proposed title and a short description of the topic
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信